|
29.4.2011 |
MT |
Il-Ġurnal Uffiċjali tal-Unjoni Ewropea |
C 128/1 |
Sommarju ta' deċiżjonijiet tal-Unjoni Ewropea dwar l-awtorizzazzjonijiet għat-tqegħid fis-suq tal-prodotti mediċinali mill-1 ta' Jannar 2011 sat-28 ta' Frar 2011
(Ippubblikat skont l-Artikolu 13 jew l-Artikolu 38 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill (1) )
2011/C 128/01
— Ħruġ ta' awtorizzazzjoni għat-tqegħid fis-suq (Artikolu 13 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill): Aċċettat
|
Data tad-deċiżjoni |
Isem tal-prodott mediċinali |
INN (Denominazzjoni Internazzjonali Komuni) |
Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq |
Numru tal-entrata fir-Reġistru Komunitarju |
Forma farmaċewtika |
Kodiċi ATC (Kodiċi Anatomiku Terapewtiku Kimiku) |
Data ta' notifika |
||
|
6.1.2011 |
Potactasol |
topotecan |
|
EU/1/10/660/001-002 |
Trab għal konċentrat għal soluzzjoni għall-infużjoni |
L01XX17 |
10.1.2011 |
||
|
21.1.2011 |
Docetaxel Teva Pharma |
docetaxel |
|
EU/1/10/662/001-002 |
Konċentrat u solvent għal soluzzjoni għall-infużjoni |
L01CD02 |
26.1.2011 |
||
|
21.1.2011 |
Iasibon |
ibandronic acid |
|
EU/1/10/659/001-010 |
Konċentrat għal soluzzjoni għal infużjoni Pillola miksija b’rita |
M05BA06 |
25.1.2011 |
||
|
27.1.2011 |
Fluenz |
tilqima kontra l-influwenza (ħajja attenwata, nażali) |
|
EU/1/10/661/001-002 |
Sprej ta’ l-imnieħer, suspensjoni |
J07BB03 |
1.2.2011 |
||
|
18.2.2011 |
Entacapone Teva |
entacapone |
|
EU/1/10/665/001-004 |
Pillola miksija b’rita |
N04BX02 |
22.2.2011 |
||
|
28.2.2011 |
Daliresp |
roflumilast |
|
EU/1/11/668/001-003 |
Pillola miksija b’rita |
R03DX07 |
2.3.2011 |
||
|
28.2.2011 |
Esbriet |
Pirfenidone |
|
EU/1/11/667/001-003 |
Kapsula, iebsa |
L04AX05 |
2.3.2011 |
||
|
28.2.2011 |
Lamivudine / Zidovudine Teva |
Lamivudine/Zidovudine |
|
EU/1/10/663/001-002 |
Pillola miksija b’rita |
J05AR01 |
2.3.2011 |
||
|
28.2.2011 |
Libertek |
roflumilast |
|
EU/1/11/666/001-003 |
Pillola miksija b’rita |
R03DX07 |
2.3.2011 |
||
|
28.2.2011 |
Xiapex |
collagenase clostridium histolyticum |
|
EU/1/11/671/001 |
Trab u solvent għal soluzzjoni għall-injezzjoni |
M09AB02 |
2.3.2011 |
— Modifika ta' awtorizzazzjoni għat-tqegħid fis-suq (Artikolu 13 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill): Aċċettat
|
Data tad-deċiżjoni |
Isem tal-prodott mediċinali |
Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq |
Numru tal-entrata fir-Reġistru Komunitarju |
Data ta' notifika |
||
|
6.1.2011 |
Invirase |
|
EU/1/96/026/001-002 |
10.1.2011 |
||
|
6.1.2011 |
Irbesartan HCT Winthrop |
|
EU/1/06/377/001-028 |
11.1.2011 |
||
|
6.1.2011 |
Irbesartan Winthrop |
|
EU/1/06/376/001-033 |
11.1.2011 |
||
|
6.1.2011 |
Lucentis |
|
EU/1/06/374/001 |
11.1.2011 |
||
|
6.1.2011 |
Rapamune |
|
EU/1/01/171/001 EU/1/01/171/007-010 EU/1/01/171/013-014 |
11.1.2011 |
||
|
6.1.2011 |
Resolor |
|
EU/1/09/581/001-008 |
11.1.2011 |
||
|
6.1.2011 |
Tepadina |
|
EU/1/10/622/001-002 |
11.1.2011 |
||
|
6.1.2011 |
Yttriga |
|
EU/1/05/322/001 |
10.1.2011 |
||
|
11.1.2011 |
IntronA |
|
EU/1/99/127/011-039 EU/1/99/127/041-044 |
18.1.2011 |
||
|
11.1.2011 |
Pantoloc Control |
|
EU/1/09/519/001-004 |
13.1.2011 |
||
|
11.1.2011 |
Rapiscan |
|
EU/1/10/643/001 |
13.1.2010 |
||
|
13.1.2011 |
Clopidogrel Winthrop |
|
EU/1/08/465/001-020 |
17.1.2011 |
||
|
13.1.2011 |
Copalia |
|
EU/1/06/372/037-039 |
17.1.2010 |
||
|
13.1.2011 |
INOmax |
|
EU/1/01/194/001-002 |
18.1.2011 |
||
|
13.1.2011 |
Iscover |
|
EU/1/98/070/001a-001b EU/1/98/070/002a-002b EU/1/98/070/003a-003b EU/1/98/070/004a-004b EU/1/98/070/005a-005b EU/1/98/070/006a-006b EU/1/98/070/007a-007b EU/1/98/070/008-010 EU/1/98/070/011a-011b EU/1/98/070/012 |
17.1.2011 |
||
|
13.1.2011 |
Nimvastid |
|
EU/1/09/525/001-050 |
17.1.2011 |
||
|
13.1.2011 |
Plavix |
|
EU/1/98/069/001a-001b EU/1/98/069/002a-002b EU/1/98/069/003a-003b EU/1/98/069/004a-004b EU/1/98/069/005a-005b EU/1/98/069/006a-006b EU/1/98/069/007a-007b EU/1/98/069/008-010 EU/1/98/069/011a-011b EU/1/98/069/012 |
17.1.2011 |
||
|
17.1.2011 |
Cancidas |
|
EU/1/01/196/001 EU/1/01/196/003 |
19.1.2011 |
||
|
17.1.2011 |
Kuvan |
|
EU/1/08/481/001-003 |
19.1.2011 |
||
|
17.1.2011 |
Nevanac |
|
EU/1/07/433/001 |
19.1.2011 |
||
|
21.1.2011 |
Abilify |
|
EU/1/04/276/001-020 EU/1/04/276/024-036 |
25.1.2011 |
||
|
21.1.2011 |
Adenuric |
|
EU/1/08/447/001-004 |
25.1.2011 |
||
|
21.1.2011 |
Arzerra |
|
EU/1/10/625/001-002 |
26.1.2011 |
||
|
21.1.2011 |
Cubicin |
|
EU/1/05/328/001-004 |
25.1.2011 |
||
|
21.1.2011 |
Enbrel |
|
EU/1/99/126/001-021 |
25.1.2011 |
||
|
21.1.2011 |
Humira |
|
EU/1/03/256/001-010 |
25.1.2011 |
||
|
21.1.2011 |
INOmax |
|
EU/1/01/194/001-002 |
25.1.2011 |
||
|
21.1.2011 |
Karvea |
|
EU/1/97/049/001-039 |
26.1.2011 |
||
|
21.1.2011 |
Kuvan |
|
EU/1/08/481/001-003 |
25.1.2011 |
||
|
21.1.2011 |
Mixtard |
|
EU/1/02/231/001-023 EU/1/02/231/036-037 |
25.1.2011 |
||
|
21.1.2011 |
Multaq |
|
EU/1/09/591/001-004 |
25.1.2011 |
||
|
21.1.2011 |
Olazax Disperzi |
|
EU/1/09/592/001-005 |
25.1.2011 |
||
|
21.1.2011 |
Pandemrix |
|
EU/1/08/452/001 |
26.1.2011 |
||
|
21.1.2011 |
Pradaxa |
|
EU/1/08/442/001-008 |
25.1.2011 |
||
|
21.1.2011 |
Rapamune |
|
EU/1/01/171/001 EU/1/01/171/007-010 EU/1/01/171/013-014 |
26.1.2011 |
||
|
21.1.2011 |
Rasilez |
|
EU/1/07/405/001-040 |
25.1.2011 |
||
|
21.1.2011 |
Revatio |
|
EU/1/05/318/002 |
25.1.2011 |
||
|
21.1.2011 |
Revlimid |
|
EU/1/07/391/001-004 |
26.1.2011 |
||
|
21.1.2011 |
RotaTeq |
|
EU/1/06/348/001-002 |
26.1.2011 |
||
|
21.1.2011 |
Sprimeo |
|
EU/1/07/407/001-020 |
26.1.2011 |
||
|
21.1.2011 |
Temomedac |
|
EU/1/09/605/001-012 |
26.1.2011 |
||
|
21.1.2011 |
Thymanax |
|
EU/1/08/498/001-008 |
25.1.2011 |
||
|
21.1.2011 |
Valdoxan |
|
EU/1/08/499/001-008 |
26.1.2011 |
||
|
21.1.2011 |
Yentreve |
|
EU/1/04/280/001-008 |
25.1.2011 |
||
|
24.1.2011 |
Apidra |
|
EU/1/04/285/001-036 |
27.1.2011 |
||
|
24.1.2011 |
Ceplene |
|
EU/1/08/477/001 |
27.1.2011 |
||
|
24.1.2011 |
Dafiro |
|
EU/1/06/371/001-039 |
27.1.2011 |
||
|
24.1.2011 |
Eucreas |
|
EU/1/07/425/001-018 |
27.1.2011 |
||
|
24.1.2011 |
Galvus |
|
EU/1/07/414/001-010 EU/1/07/414/018 |
27.1.2011 |
||
|
24.1.2011 |
Isentress |
|
EU/1/07/436/001-002 |
27.1.2011 |
||
|
24.1.2011 |
Jalra |
|
EU/1/08/485/001-011 |
27.1.2011 |
||
|
24.1.2011 |
Lantus |
|
EU/1/00/134/001-037 |
27.1.2011 |
||
|
24.1.2011 |
NutropinAq |
|
EU/1/00/164/003-005 |
27.1.2011 |
||
|
24.1.2011 |
Olanzapine Glenmark |
|
EU/1/09/587/001-017 |
27.1.2011 |
||
|
24.1.2011 |
Olanzapine Glenmark Europe |
|
EU/1/09/588/001-012 |
27.1.2011 |
||
|
24.1.2011 |
Optisulin |
|
EU/1/00/133/001-032 |
27.1.2011 |
||
|
24.1.2011 |
Pelzont |
|
EU/1/08/460/009-011 EU/1/08/460/013-014 |
26.1.2011 |
||
|
24.1.2011 |
Rotarix |
|
EU/1/05/330/001-011 |
27.1.2011 |
||
|
24.1.2011 |
SonoVue |
|
EU/1/01/177/002 |
27.1.2011 |
||
|
24.1.2011 |
Synflorix |
|
EU/1/09/508/001-010 |
27.1.2011 |
||
|
24.1.2011 |
Torisel |
|
EU/1/07/424/001 |
27.1.2011 |
||
|
24.1.2011 |
Tredaptive |
|
EU/1/08/459/009-011 EU/1/08/459/013-014 |
26.1.2011 |
||
|
24.1.2011 |
Trevaclyn |
|
EU/1/08/458/009-011 EU/1/08/458/013-014 |
26.1.2011 |
||
|
24.1.2011 |
Vistide |
|
EU/1/97/037/001 |
27.1.2011 |
||
|
24.1.2011 |
Xarelto |
|
EU/1/08/472/001-010 |
27.1.2011 |
||
|
24.1.2011 |
Xiliarx |
|
EU/1/08/486/001-011 |
27.1.2011 |
||
|
26.1.2011 |
Naglazyme |
|
EU/1/05/324/001-002 |
27.1.2011 |
||
|
27.1.2011 |
Adrovance |
|
EU/1/06/364/001-009 |
1.2.2011 |
||
|
27.1.2011 |
Alimta |
|
EU/1/04/290/001-002 |
1.2.2011 |
||
|
27.1.2011 |
Cymbalta |
|
EU/1/04/296/001-009 |
31.1.2011 |
||
|
27.1.2011 |
Herceptin |
|
EU/1/00/145/001 |
1.2.2011 |
||
|
27.1.2011 |
Icandra |
|
EU/1/08/484/001-018 |
1.2.2011 |
||
|
27.1.2011 |
Menveo |
|
EU/1/10/614/001 |
31.1.2011 |
||
|
27.1.2011 |
Nonafact |
|
EU/1/01/186/001-002 |
1.2.2011 |
||
|
27.1.2011 |
Orgalutran |
|
EU/1/00/130/001-002 |
31.1.2011 |
||
|
27.1.2011 |
Ranexa |
|
EU/1/08/462/001-012 |
1.2.2011 |
||
|
27.1.2011 |
Rasilez HCT |
|
EU/1/08/491/001-080 |
1.2.2011 |
||
|
27.1.2011 |
Regranex |
|
EU/1/99/101/001 |
31.1.2011 |
||
|
27.1.2011 |
Remicade |
|
EU/1/99/116/001-005 |
1.2.2011 |
||
|
27.1.2011 |
Ribavirin Mylan |
|
EU/1/10/634/001-004 |
23.2.2011 |
||
|
27.1.2011 |
RotaTeq |
|
EU/1/06/348/001-002 |
1.2.2011 |
||
|
27.1.2011 |
Sebivo |
|
EU/1/07/388/001-003 |
1.2.2011 |
||
|
27.1.2011 |
Simponi |
|
EU/1/09/546/001-004 |
31.1.2011 |
||
|
27.1.2011 |
Xeristar |
|
EU/1/04/297/001-008 |
1.2.2011 |
||
|
27.1.2011 |
Zomarist |
|
EU/1/08/483/001-018 |
1.2.2011 |
||
|
1.2.2011 |
Ariclaim |
|
EU/1/04/283/008-012 |
3.2.2011 |
||
|
1.2.2011 |
Emend |
|
EU/1/03/262/001-008 |
3.2.2011 |
||
|
1.2.2011 |
Exforge |
|
EU/1/06/370/001-039 |
3.2.2011 |
||
|
1.2.2011 |
Fosavance |
|
EU/1/05/310/001-009 |
3.2.2011 |
||
|
1.2.2011 |
Imprida |
|
EU/1/06/373/001-039 |
3.2.2011 |
||
|
1.2.2011 |
INCRELEX |
|
EU/1/07/402/001 |
3.2.2011 |
||
|
1.2.2011 |
Insulin Human Winthrop |
|
EU/1/06/368/001-168 |
3.2.2011 |
||
|
1.2.2011 |
Insuman |
|
EU/1/97/030/028-195 |
3.2.2011 |
||
|
1.2.2011 |
Irbesartan Teva |
|
EU/1/09/576/001-039 |
3.2.2011 |
||
|
1.2.2011 |
Nivestim |
|
EU/1/10/631/001-009 |
3.2.2011 |
||
|
1.2.2011 |
Orfadin |
|
EU/1/04/303/001-003 |
3.2.2011 |
||
|
1.2.2011 |
Riprazo |
|
EU/1/07/409/001-020 |
3.2.2011 |
||
|
1.2.2011 |
Votrient |
|
EU/1/10/628/001-004 |
3.2.2011 |
||
|
2.2.2011 |
Nplate |
|
EU/1/08/497/001-008 |
4.2.2011 |
||
|
2.2.2011 |
Prevenar |
|
EU/1/00/167/001-008 |
4.2.2011 |
||
|
2.2.2011 |
Prolia |
|
EU/1/10/618/001-004 |
4.2.2011 |
||
|
2.2.2011 |
Replagal |
|
EU/1/01/189/001-006 |
4.2.2011 |
||
|
2.2.2011 |
Vantavo |
|
EU/1/09/572/001-009 |
4.2.2011 |
||
|
8.2.2011 |
Biopoin |
|
EU/1/09/565/001-028 |
10.2.2011 |
||
|
8.2.2011 |
Temodal |
|
EU/1/98/096/001-025 |
14.2.2011 |
||
|
9.2.2011 |
Cimzia |
|
EU/1/09/544/001-002 |
11.2.2011 |
||
|
9.2.2011 |
Karvezide |
|
EU/1/98/085/001-034 |
11.2.2011 |
||
|
9.2.2011 |
Olazax |
|
EU/1/09/597/001-005 |
11.2.2011 |
||
|
9.2.2011 |
Peyona |
|
EU/1/09/528/001-002 |
11.2.2011 |
||
|
9.2.2011 |
Tesavel |
|
EU/1/07/435/001-018 |
11.2.2011 |
||
|
9.2.2011 |
Xelevia |
|
EU/1/07/382/001-018 |
11.2.2011 |
||
|
11.2.2011 |
Aprovel |
|
EU/1/97/046/001-039 |
15.2.2011 |
||
|
11.2.2011 |
Azarga |
|
EU/1/08/482/001-002 |
15.2.2011 |
||
|
11.2.2011 |
Brinavess |
|
EU/1/10/645/001-002 |
15.2.2011 |
||
|
11.2.2011 |
Clopidogrel Krka |
|
EU/1/09/556/001-011 |
15.2.2011 |
||
|
11.2.2011 |
CoAprovel |
|
EU/1/98/086/001-034 |
15.2.2011 |
||
|
11.2.2011 |
Crixivan |
|
EU/1/96/024/001-005 EU/1/96/024/008 EU/1/96/024/010 |
15.2.2011 |
||
|
11.2.2011 |
Eporatio |
|
EU/1/09/573/001-028 |
15.2.2011 |
||
|
11.2.2011 |
Januvia |
|
EU/1/07/383/001-018 |
15.2.2011 |
||
|
11.2.2011 |
Rilonacept Regeneron |
|
EU/1/09/582/001 |
15.2.2011 |
||
|
11.2.2011 |
Zutectra |
|
EU/1/09/600/001 |
15.2.2011 |
||
|
11.2.2011 |
Zyllt |
|
EU/1/09/553/001-010 |
15.2.2011 |
||
|
18.2.2011 |
Actrapid |
|
EU/1/02/230/001-007 EU/1/02/230/016-017 |
22.2.2011 |
||
|
18.2.2011 |
Elaprase |
|
EU/1/06/365/001-003 |
22.2.2011 |
||
|
18.2.2011 |
Keppra |
|
EU/1/00/146/001-032 |
22.2.2011 |
||
|
18.2.2011 |
Mimpara |
|
EU/1/04/292/001-012 |
22.2.2011 |
||
|
18.2.2011 |
Optaflu |
|
EU/1/07/394/001-009 |
22.2.2011 |
||
|
18.2.2011 |
Renagel |
|
EU/1/99/123/005-013 |
22.2.2011 |
||
|
21.2.2011 |
Arzerra |
|
EU/1/10/625/001-003 |
25.2.2011 |
||
|
21.2.2011 |
Baraclude |
|
EU/1/06/343/001-007 |
28.2.2011 |
||
|
21.2.2011 |
Cervarix |
|
EU/1/07/419/001-012 |
25.2.2011 |
||
|
21.2.2011 |
Cialis |
|
EU/1/02/237/001-009 |
23.2.2011 |
||
|
21.2.2011 |
Clopidogrel Teva |
|
EU/1/09/540/001-016 |
24.2.2011 |
||
|
21.2.2011 |
Competact |
|
EU/1/06/354/001-011 |
23.2.2011 |
||
|
21.2.2011 |
Conbriza |
|
EU/1/09/511/001-005 |
23.2.2011 |
||
|
21.2.2011 |
Dukoral |
|
EU/1/03/263/001-003 |
1.3.2011 |
||
|
21.2.2011 |
Dynastat |
|
EU/1/02/209/001-008 |
23.2.2011 |
||
|
21.2.2011 |
Efficib |
|
EU/1/08/457/001-016 |
24.2.2011 |
||
|
21.2.2011 |
Enbrel |
|
EU/1/99/126/001-021 |
25.2.2011 |
||
|
21.2.2011 |
Firazyr |
|
EU/1/08/461/001-002 |
24.2.2011 |
||
|
21.2.2011 |
Glivec |
|
EU/1/01/198/001-013 |
28.2.2011 |
||
|
21.2.2011 |
Humira |
|
EU/1/03/256/001-010 |
23.2.2011 |
||
|
21.2.2011 |
Insulatard |
|
EU/1/02/233/005-007 |
25.2.2011 |
||
|
21.2.2011 |
Intanza |
|
EU/1/08/505/001-006 |
23.2.2011 |
||
|
21.2.2011 |
Ivemend |
|
EU/1/07/437/001-004 |
24.2.2011 |
||
|
21.2.2011 |
Janumet |
|
EU/1/08/455/001-016 |
24.2.2011 |
||
|
21.2.2011 |
Kineret |
|
EU/1/02/203/001-004 |
25.2.2011 |
||
|
21.2.2011 |
Levemir |
|
EU/1/04/278/001-003 |
28.2.2011 |
||
|
21.2.2011 |
Myozyme |
|
EU/1/06/333/001-003 |
28.2.2011 |
||
|
21.2.2011 |
Neupro |
|
EU/1/05/331/001-055 |
25.2.2011 |
||
|
21.2.2011 |
Pritor |
|
EU/1/98/089/001-022 |
25.2.2011 |
||
|
21.2.2011 |
PritorPlus |
|
EU/1/02/215/001-021 |
28.2.2011 |
||
|
21.2.2011 |
Protaphane |
|
EU/1/02/234/005-007 |
25.2.2011 |
||
|
21.2.2011 |
Protopic |
|
EU/1/02/201/001-006 |
28.2.2011 |
||
|
21.2.2011 |
Qutenza |
|
EU/1/09/524/001-002 |
25.2.2011 |
||
|
21.2.2011 |
Ranexa |
|
EU/1/08/462/001-012 |
25.2.2011 |
||
|
21.2.2011 |
Rasilez |
|
EU/1/07/405/001-040 |
25.2.2011 |
||
|
21.2.2011 |
Rasilez HCT |
|
EU/1/08/491/001-080 |
25.2.2011 |
||
|
21.2.2011 |
Remicade |
|
EU/1/99/116/001-005 |
25.2.2011 |
||
|
21.2.2011 |
Ribavirin Teva |
|
EU/1/09/509/001-004 |
24.2.2011 |
||
|
21.2.2011 |
Ribavirin Teva Pharma BV |
|
EU/1/09/527/001-016 |
24.2.2011 |
||
|
21.2.2011 |
Riprazo |
|
EU/1/07/409/001-020 |
28.2.2011 |
||
|
21.2.2011 |
Ristaben |
|
EU/1/10/621/001-018 |
24.2.2011 |
||
|
21.2.2011 |
Ristfor |
|
EU/1/10/620/001-016 |
24.2.2011 |
||
|
21.2.2011 |
Simponi |
|
EU/1/09/546/001-004 |
23.2.2011 |
||
|
21.2.2011 |
Sprimeo |
|
EU/1/07/407/001-020 |
28.3.2011 |
||
|
21.2.2011 |
Stocrin |
|
EU/1/99/111/001-005 EU/1/99/111/008-011 |
25.2.2011 |
||
|
21.2.2011 |
Tamiflu |
|
EU/1/02/222/001-004 |
23.2.2011 |
||
|
21.2.2011 |
Tysabri |
|
EU/1/06/346/001 |
23.2.2011 |
||
|
21.2.2011 |
Velmetia |
|
EU/1/08/456/001-016 |
24.2.2011 |
||
|
21.2.2011 |
Ventavis |
|
EU/1/03/255/001-008 |
23.2.2011 |
||
|
21.2.2011 |
Volibris |
|
EU/1/08/451/001-004 |
2.3.2011 |
||
|
21.2.2011 |
Zylagren |
|
EU/1/09/558/001-010 |
28.2.2011 |
||
|
21.2.2011 |
Zyprexa |
|
EU/1/96/022/016-017 |
23.2.2011 |
||
|
28.2.2011 |
Altargo |
|
EU/1/07/390/001-004 |
4.3.2011 |
||
|
28.2.2011 |
Aranesp |
|
EU/1/01/185/001-022 EU/1/01/185/031-111 |
4.3.2011 |
||
|
28.2.2011 |
Arixtra |
|
EU/1/02/206/001-035 |
2.3.2011 |
||
|
28.2.2011 |
Avastin |
|
EU/1/04/300/001-002 |
4.3.2011 |
||
|
28.2.2011 |
Baraclude |
|
EU/1/06/343/001-007 |
3.3.2011 |
||
|
28.2.2011 |
Clopidogrel Qualimed |
|
EU/1/09/557/001-010 |
4.3.2011 |
||
|
28.2.2011 |
Clopidogrel TAD |
|
EU/1/09/555/001-009 |
4.3.2011 |
||
|
28.2.2011 |
Fabrazyme |
|
EU/1/01/188/001-006 |
4.3.2011 |
||
|
28.2.2011 |
Firazyr |
|
EU/1/08/461/001-002 |
4.3.2011 |
||
|
28.2.2011 |
IDflu |
|
EU/1/08/507/001-006 |
3.3.2011 |
||
|
28.2.2011 |
Ilaris |
|
EU/1/09/564/001-002 |
4.3.2011 |
||
|
28.2.2011 |
Invanz |
|
EU/1/02/216/001-002 |
3.3.2011 |
||
|
28.2.2011 |
Kaletra |
|
EU/1/01/172/001-008 |
4.3.2011 |
||
|
28.2.2011 |
Kinzalkomb |
|
EU/1/02/214/001-015 |
2.3.2011 |
||
|
28.2.2011 |
Kinzalmono |
|
EU/1/98/091/001-014 |
2.3.2011 |
||
|
28.2.2011 |
Micardis |
|
EU/1/98/090/001-020 |
2.3.2011 |
||
|
28.2.2011 |
MicardisPlus |
|
EU/1/02/213/001-023 |
3.3.2011 |
||
|
28.2.2011 |
NovoMix |
|
EU/1/00/142/004-005 EU/1/00/142/009-025 |
3.3.2011 |
||
|
28.2.2011 |
Omnitrope |
|
EU/1/06/332/001-009 |
2.3.2011 |
||
|
28.2.2011 |
Onglyza |
|
EU/1/09/545/011-015 |
3.3.2011 |
||
|
28.2.2011 |
Onglyza |
|
EU/1/09/545/001-010 |
3.3.2011 |
||
|
28.2.2011 |
Osigraft |
|
EU/1/01/179/001 |
4.3.2011 |
||
|
28.2.2011 |
Osseor |
|
EU/1/04/287/001-006 |
4.3.2011 |
||
|
28.2.2011 |
PegIntron |
|
EU/1/00/131/001-050 |
3.3.2011 |
||
|
28.2.2011 |
PREZISTA |
|
EU/1/06/380/001-005 |
4.3.2011 |
||
|
28.2.2011 |
ProQuad |
|
EU/1/05/323/001-013 |
2.3.2011 |
||
|
28.2.2011 |
Protelos |
|
EU/1/04/288/001-006 |
4.3.2011 |
||
|
28.2.2011 |
Quadramet |
|
EU/1/97/057/001 |
4.4.2011 |
||
|
28.2.2011 |
RotaTeq |
|
EU/1/06/348/001-002 |
3.3.2011 |
||
|
28.2.2011 |
Siklos |
|
EU/1/07/397/001-004 |
3.3.2011 |
||
|
28.2.2011 |
Tracleer |
|
EU/1/02/220/001-006 |
3.3.2011 |
||
|
28.2.2011 |
Vedrop |
|
EU/1/09/533/001-003 |
3.3.2011 |
||
|
28.2.2011 |
Ytracis |
|
EU/1/03/250/001 |
4.3.2011 |
— Irtirar ta' awtorizzazzjoni għat-tqegħid fis-suq (Artikolu 13 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill)
|
Data tad-deċiżjoni |
Isem tal-prodott mediċinali |
Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq |
Numru tal-entrata fir-Reġistru Komunitarju |
Data ta' notifika |
||
|
6.1.2011 |
Thelin |
|
EU/1/06/353/001-005 |
11.1.2011 |
||
|
1.2.2011 |
Clopidogrel 1A Pharma |
|
EU/1/09/542/001-007 |
3.2.2011 |
— Ħruġ ta' awtorizzazzjoni għat-tqegħid fis-suq (Artikolu 38 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill (2)): Aċċettat
|
Data tad-deċiżjoni |
Isem tal-prodott mediċinali |
INN (Denominazzjoni Internazzjonali Komuni) |
Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq |
Numru tal-entrata fir-Reġistru Komunitarju |
Forma farmaċewtika |
Kodiċi ATC (Kodiċi Anatomiku Terapewtiku Kimiku) |
Data ta' notifika |
||
|
27.1.2011 |
Hiprabovis IBR Marker Live |
Virus tal-Ħerpes tal-Bovini ħaj gE<sup>-</sup> tk<sup>-</sup> bil-ġene mneħħi darbtejn tip 1 (BoHV-1), razza CEDDEL |
|
EU/2/10/114/001-002 |
Lajofiliżejt għal suspensjoni |
QI02AD01 |
1.2.2011 |
||
|
11.2.2011 |
Comfortis |
spinosad |
|
EU/2/10/115/001-010 |
Pilloli li tomgħodhom |
QP53BX03 |
15.2.2011 |
||
|
18.2.2011 |
Activyl |
indoxacarb |
|
EU/2/10/118/001-014 |
Taħlita likwida għall-użu lokalizzat |
QP53AX27 |
22.2.2011 |
||
|
18.2.2011 |
Cimalgex |
Cimicoxib |
|
EU/2/10/119/001-012 |
Pillola |
QM01AH93 |
24.2.2011 |
||
|
18.2.2011 |
Purevax Rabies |
Virus rikombinat tar- Rabies canarypox (vCP65) |
|
EU/2/10/117/001-002 |
Suspensjoni għall-injezzjoni |
QI06AX |
22.2.2011 |
||
|
21.2.2011 |
Melosus |
Meloxicam |
|
EU/2/10/116/001-004 |
Suspensjoni Orali |
QM01AC06 |
24.2.2011 |
— Modifika ta' awtorizzazzjoni għat-tqegħid fis-suq (Artikolu 38 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill): Aċċettat
|
Data tad-deċiżjoni |
Isem tal-prodott mediċinali |
Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq |
Numru tal-entrata fir-Reġistru Komunitarju |
Data ta' notifika |
||
|
06.1.2011 |
Econor |
|
EU/2/98/010/004-006 EU/2/98/010/017-018 EU/2/98/010/021-025 |
11.1.2011 |
||
|
13.1.2011 |
Duvaxyn WNV |
|
EU/2/08/086/001-003 |
18.1.2011 |
||
|
13.1.2011 |
Palladia |
|
EU/2/09/100/001-003 |
17.1.2011 |
||
|
17.1.2011 |
Zolvix |
|
EU/2/09/101/001-010 |
19.1.2011 |
||
|
21.1.2011 |
Dicural |
|
EU/2/97/003/001-018 |
25.1.2011 |
||
|
21.1.2011 |
Zulvac 8 Ovis |
|
EU/2/09/104/001-002 |
26.1.2011 |
||
|
24.1.2011 |
Poulvac FluFend H5N3 RG |
|
EU/2/06/060/001-002 |
27.1.2011 |
||
|
24.1.2011 |
Rheumocam |
|
EU/2/07/078/001-010 |
26.1.2011 |
||
|
27.1.2011 |
Ingelvac CircoFLEX |
|
EU/2/07/079/001-004 |
01.2.2011 |
||
|
27.1.2011 |
Meloxidyl |
|
EU/2/06/070/005-007 |
01.2.2011 |
||
|
11.2.2011 |
SevoFlo |
|
EU/2/02/035/007 |
15.2.2011 |
— Sospensjoni ta' awtorizzazzjoni għat-tqegħid fis-suq (Artikolu 45 tar-Regolament (KE) Nru 726/2004 tal-Parlament Ewropew u tal-Kunsill)
|
Data tad-deċiżjoni |
Isem tal-prodott mediċinali |
Detentur tal-awtorizzazzjoni għat-tqegħid fis-suq |
Numru tal-entrata fir-Reġistru Komunitarju |
Data ta' notifika |
||
|
24.1.2011 |
Acticam |
|
EU/2/08/088/001-003 |
26.1.2011 |
Kull min jixtieq jikkonsulta r-rapport ta' evalwazzjoni pubblika dwar il-prodotti mediċinali kkonċernati u d-deċiżjonijiet marbuta magħhom għandu jikkuntattja lil:
|
The European Medicines Agency |
|
7, Westferry Circus, Canary Wharf |
|
UK - LONDON E14 4H |